326 related articles for article (PubMed ID: 12128120)
1. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos C; Turley H; Talks K; Gatter KC; Harris AL
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1192-202. PubMed ID: 12128120
[TBL] [Abstract][Full Text] [Related]
2. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
Giatromanolaki A; Sivridis E; Kouskoukis C; Gatter KC; Harris AL; Koukourakis MI
Melanoma Res; 2003 Oct; 13(5):493-501. PubMed ID: 14512791
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E
Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL
Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514
[TBL] [Abstract][Full Text] [Related]
6. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
7. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
Giatromanolaki A; Sivridis E; Maltezos E; Papazoglou D; Simopoulos C; Gatter KC; Harris AL; Koukourakis MI
J Clin Pathol; 2003 Mar; 56(3):209-13. PubMed ID: 12610101
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
Schöning JP; Monteiro M; Gu W
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
11. Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.
Szendrői A; Szász AM; Kardos M; Tőkés AM; Idan R; Szűcs M; Kulka J; Nyirády P; Szendrői M; Szállási Z; Győrffy B; Tímár J
Oncotarget; 2016 Jul; 7(27):42086-42098. PubMed ID: 27244898
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.
Beasley NJ; Leek R; Alam M; Turley H; Cox GJ; Gatter K; Millard P; Fuggle S; Harris AL
Cancer Res; 2002 May; 62(9):2493-7. PubMed ID: 11980639
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
Giatromanolaki A; Koukourakis MI; Pezzella F; Sivridis E; Turley H; Harris AL; Gatter KC
Hematol Oncol; 2008 Dec; 26(4):219-24. PubMed ID: 18461646
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
Koukourakis MI; Giatromanolaki A; Sivridis E; Bougioukas G; Didilis V; Gatter KC; Harris AL;
Br J Cancer; 2003 Sep; 89(5):877-85. PubMed ID: 12942121
[TBL] [Abstract][Full Text] [Related]
15. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
[TBL] [Abstract][Full Text] [Related]
16. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
Koukourakis MI; Giatromanolaki A; Sivridis E; Pastorek J; Karapantzos I; Gatter KC; Harris AL;
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):67-71. PubMed ID: 15093900
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia Inducible Factor Expression and Angiogenesis - Analysis in the Pituitary Gland and Patterns of Death.
Kouroupi M; Sivridis E; Papazoglou D; Koukourakis MI; Giatromanolaki A
In Vivo; 2018; 32(1):185-190. PubMed ID: 29275318
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.
Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos K; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Clin Cancer Res; 2001 Nov; 7(11):3399-403. PubMed ID: 11705854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
